A novel heterozygous <i>OPA3</i> mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network

Abstract

In summary, our study provides new insights into the clinical spectrum and the pathogenesis of dominant optic atrophy caused by mutations in the OPA3 gene.